(0.00%) 5 214.00 points
(0.00%) 39 027 points
(-0.05%) 18 190 points
(-1.52%) $77.19
(0.54%) $2.22
(-0.33%) $2 316.50
(-0.65%) $27.37
(-0.96%) $978.90
(0.11%) $0.931
(0.34%) $10.94
(0.20%) $0.801
(0.34%) $91.75
Quarter results today
(bmo 2024-05-08)
Expected move: +/- 7.58%
-4.17% $ 1.380
@ $1.391
Wydano: 14 vas. 2024 @ 18:10
Zwrot: -0.79%
Poprzedni sygnał: vas. 13 - 22:52
Poprzedni sygnał:
Zwrot: 4.59 %
Live Chart Being Loaded With Signals
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies...
Stats | |
---|---|
Dzisiejszy wolumen | 902 219 |
Średni wolumen | 963 339 |
Kapitalizacja rynkowa | 348.34M |
EPS | $0 ( 2024-03-19 ) |
Następna data zysków | ( $-0.0900 ) 2024-06-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.54 |
ATR14 | $0.00400 (0.29%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-02 | Perez Jeffrey Thomas | Buy | 126 713 | Common Stock |
2024-05-02 | Kirk Randal J | Buy | 8 896 412 | Common Stock |
2024-05-02 | Kirk Randal J | Buy | 6 085 471 | Common Stock |
2024-05-02 | Kirk Randal J | Sell | 691 929 | Common Stock |
2024-04-05 | Thomasian Harry Jr. | Buy | 135 714 | Common Stock |
INSIDER POWER |
---|
67.23 |
Last 99 transactions |
Buy: 22 274 780 | Sell: 4 631 433 |
Wolumen Korelacja
Precigen Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
TATT | 0.813 |
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Precigen Inc Korelacja - Waluta/Towar
Precigen Inc Finanse
Annual | 2023 |
Przychody: | $6.23M |
Zysk brutto: | $-4.74M (-76.18 %) |
EPS: | $-0.390 |
FY | 2023 |
Przychody: | $6.23M |
Zysk brutto: | $-4.74M (-76.18 %) |
EPS: | $-0.390 |
FY | 2022 |
Przychody: | $26.91M |
Zysk brutto: | $20.57M (76.44 %) |
EPS: | $-0.400 |
FY | 2021 |
Przychody: | $103.87M |
Zysk brutto: | $45.49M (43.79 %) |
EPS: | $-0.470 |
Financial Reports:
No articles found.
Precigen Inc
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej